A Non-randomized Phase 2 Study of Alvocidib (Flavopiridol) Plus Oxaliplatin With or Without 5-FU and Leucovorin for Relapsed or Refractory Germ-Cell Tumors
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Alvocidib (Primary) ; Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Germ cell and embryonal neoplasms
- Focus Therapeutic Use
- 11 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Mar 2015 According to the ClinicalTrials.gov record, planned end date changed to 1 Aug 2015.
- 06 Mar 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Apr 2015 to 1 Aug 2015.